title: Quetiapine and the need for a thorough QT/QTc study.
authors.affiliation: From the *Department of Psychiatry, Memorial University, St John's, Newfoundland, Canada; Departments of †Psychiatry, and ‡Internal Medicine, Virginia Commonwealth University, Richmond, VA; §Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA; ∥Department of Pharmacy, and ¶Division of Cardiology and Cardiac Electrophysiology, Virginia Commonwealth University, Richmond, VA; #School of Physiology and Pharmacology and Cardiovascular Research Laboratories, University of Bristol, Bristol, UK; Departments of **Medicine and ††Cardiology, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada; and ‡‡Department of Cardiovascular Medicine, The Cardiac Center of Creighton University, Omaha, NE.
authors.forename: Mehrul
authors.initials: M
authors.lastname: Hasnain
authors.forename: W Victor R
authors.initials: WV
authors.lastname: Vieweg
authors.forename: Robert H
authors.initials: RH
authors.lastname: Howland
authors.forename: Christopher
authors.initials: C
authors.lastname: Kogut
authors.forename: Ericka L
authors.initials: EL
authors.lastname: Breden Crouse
authors.forename: Jayanthi N
authors.initials: JN
authors.lastname: Koneru
authors.forename: Jules C
authors.initials: JC
authors.lastname: Hancox
authors.forename: Geneviève C
authors.initials: GC
authors.lastname: Digby
authors.forename: Adrian
authors.initials: A
authors.lastname: Baranchuk
authors.forename: Anand
authors.initials: A
authors.lastname: Deshmukh
authors.forename: Ananda K
authors.initials: AK
authors.lastname: Pandurangi
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003987:Dibenzothiazepines / Q000009:adverse effects*; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels / Q000037:antagonists & inhibitors / Q000378:metabolism; D019317:Evidence-Based Medicine; D006329:Heart Conduction System / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D026902:Potassium Channel Blockers / Q000009:adverse effects; D000069348:Quetiapine Fumarate; D018570:Risk Assessment; D012307:Risk Factors; D016171:Torsades de Pointes / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; D026902:Potassium Channel Blockers; D000069348:Quetiapine Fumarate